Treatment method

Details for Australian Patent Application No. 2006320535 (hide)

Owner SmithKline Beecham Corporation

Inventors Levick, Mark; Miller, William Henry; Brigandi, Richard Anthony

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006320535

PCT Pub. Number WO2007/064752

Priority 60/740,478 29.11.05 US

Filing date 29 November 2006

Wipo publication date 7 June 2007

Acceptance publication date 23 September 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/064752 Priority application(s): WO2007/064752

23 September 2010 Application Accepted

  Published as AU-B-2006320535

16 December 2010 Alteration of Name

  The name of the applicant has been altered to GlaxoSmithKline LLC 2007

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006320538-Treatment of xerostomia with a sulfurcontaining antioxidant

2006320516-GRG23 and GRG51 genes conferring herbicide resistance